Invitae Corp. is a company in the U.S. stock market and it is a holding in 42 U.S.-traded ETFs. NVTA has around 29.9M shares in the U.S. ETF market. The largest ETF holder of NVTA is the ARK Innovation ETF (ARKK), with approximately 15.12M shares. Investors may also find of interest that the ETF with the largest allocation to NVTA stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 12.06%. On average, U.S. ETFs allocate 0.99% of NVTA to their portfolios.
Additionally, NVTA is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NVTA as a holding is the ARK Genomic Revolution ETF (ARKG), with a return of 65.13%.